首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Trends in cancer

缩写:

ISSN:2405-8033

e-ISSN:2405-8025

IF/分区:17.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1077
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zihan Xia,Olivier De Wever Zihan Xia
The plasticity of cancer-associated fibroblasts (CAFs) refers to their ability to adopt a spectrum of distinct phenotypes or states in response to dynamic changes within the tumor microenvironment (TME). Recent advances in single-cell techn...
Jessica L Chitty,Thomas R Cox Jessica L Chitty
Significant advances in matrix biology research have enhanced our understanding of individual matrix components and extracellular matrix (ECM) signalling. The dysregulation of the ECM during the development of solid tumours is a critical ar...
John B Haanen John B Haanen
A recent study published in Nature Medicine shows that adoptive cell therapy using neoantigen-selected tumor-infiltrating lymphocytes (TIL) is feasible in refractory metastatic gastrointestinal (GI) cancers, showing durable responses, espec...
Pedro Berraondo,Raquel Cuesta,Fernando Aranda et al. Pedro Berraondo et al.
Despite deep and growing knowledge of cytokine functions, immunotherapies based on the control of these molecules have minimally impacted cancer patient management because of limited efficacy and narrow therapeutic windows. Opportunities to...
Yuefan Wang,Ramon U Jin,Joanne Xu et al. Yuefan Wang et al.
Gastric cancer arises from complex carcinogenic factor interactions, with limited treatment options due to the lack of targetable driver gene mutations and significant tumor heterogeneity. Recent studies have provided promising novel approa...
Katharin Shaw,René Bernards,Kimberly Stegmaier et al. Katharin Shaw et al.
Cancer cells optimize oncogenic signaling to maintain a defined range for survival. The success of targeted therapeutic inhibitors is based on suppressing signaling below this optimal fitness zone. Conversely, cancers are also susceptible t...
Ayoub Jaa,Aitziber Buque Ayoub Jaa
The tumor microenvironment (TME) comprises heterogeneous cell types that closely interact with each other. Crosstalk among the TME components determines antitumor immune responses and their sensitivity to therapies such as immunotherapy. Re...
Norihiro Goto,Judith Agudo,Ömer H Yilmaz Norihiro Goto
Most colorectal cancers (CRCs) are characterized by a low mutational burden and an immune-cold microenvironment, limiting the efficacy of immune checkpoint blockade (ICB) therapies. While advanced tumors exhibit diverse immune evasion mecha...
Michaela Luconi,Giulia Cantini,Clara Crescioli Michaela Luconi
The acknowledged relationship between metabolism and cancer retains important potential as a novel target in therapy. Reallocating glucose-lowering drugs (GLDs) in cancer treatment offers valuable perspectives for the ability of these molec...
Daehee Hwang,Whitney S Henry Daehee Hwang
Despite significant milestones in cancer immunotherapy, tumor cells often escape immune surveillance. Zhou et al. revealed that the pivotal ferroptosis suppressor glutathione peroxidase 4 (GPX4) can undergo palmitoylation by zDHHC8, enhanci...